CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Open-market buy 10% owner bought 35,000 shares at $5.58 ($195,402)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market buy 10% owner bought 50,000 shares at an average $5.73 ($286,508)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 25,900 shares at an average $4.85 ($125,666)
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · New debt or obligation · Other events
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 72,218 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
Page 18 of 44 · 872 filings